Publications Office of the EU
Supply of a medicinal product containing the active substance Danicopanum, reimbursed under the B.96 programme -treatment of patients with nocturnal paroxysmal haemoglobinuria. - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Supply of a medicinal product containing the active substance Danicopanum, reimbursed under the B.96 programme -treatment of patients with nocturnal paroxysmal haemoglobinuria. Text automatically translated in your browsing language Automatically translated

Overview
  • Awarded
    20/10/2025
  • Today
    15/11/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL814 Lubelski
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
732,719.94 PLN
Procedure details
Tender reference number
Not available
Description

1. The subject-matter of the contract is the supply of a medicinal product containing the active substance Danicopanum, reimbursed under the B.96 treatment programme for patients with nocturnal paroxysmal haemoglobinuria. 2. The detailed description and the manner of performance of the contract are set out in the OPZ, which constitutes Annex 1 to the invitation. 3. The period of validity of the subject of the contract (suitability for use) must be at least 12 months from the date of delivery to the Customer's registered office. 4. The Contractor shall ensure the labelling of the medicinal product in accordance with the Regulation of the Minister of Health of 20 February 2009 on the requirements for the labelling of the medicinal product and the content of leaflets (Journal of Laws No. Journal of Laws 2020, item 1847). 5. The Contracting Authority shall require the Contractor to include in the tender the EAN code of the medicinal product offered (if any). 6. The Ordering Party requires that the offered medicinal products be included in the Notice of the Minister of Health (so-called reimbursement) in the scope of financing drug programs and chemotherapy (if applicable). Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
PL814 Lubelski
PL Polska
CPV code

33600000 - Pharmaceutical products

33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated

Award method
Criterion:
Type: price
Description: najniższa cena
Weight (percentage, exact):
Estimated value
Not available
Final contracted value
732,719.94 PLN
Award of contract
Official name: Astra Zeneca Kft
Postal address:
Town: Budapest
Postal code: 1117
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.